Project Grant R01DK140148
Award Date
6/17/25
Completion Date
3/31/30
Dollars Obligated
$538K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Lexington, KY 40506, USA
Similar Awards
This federal Project Grant award of $293,604 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports research to understand the role of the hypothalamic adhesion G-protein coupled receptor L 1 (ADGRL1) in counteracting hypoglycemia (dangerously low blood glucose levels). The primary research aims are to: 1) Establish the contribution of ADGRL1 in the ventromedial nucleus of the hypothalamus...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports the development of novel dual agonist biologic drug candidates to treat diabetics with impaired awareness of hypoglycemia (IAH). The $929,940 award will fund manufacturing, formulation, efficacy validation, and safety studies on 3 lead drug candidates over a 2-year period from...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Brigham Young University a $568,075 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports research to determine the role of the NR4A1 protein in regulating the GLP-1R and DYRK1A pathways, which are critical for expanding functional beta-cell mass as a potential treatment for type 1 and type 2 diabetes. The research aims to elucidate the...
This $288,980 Project Grant award, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support research to investigate the mechanisms by which pancreatic beta and delta cells coordinate insulin and somatostatin secretion in response to high glucose levels. The research, conducted by the University of California, Davis, aims to determine the relative...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $120,792 to the University of Alabama at Birmingham (UAB) to conduct research on the role of glucagon-like peptide-1 receptor (GLP-1R) agonism in the central amygdala and its effects on appetite and food intake. The research aims to characterize the neural physiology of...
This federal Project Grant award, valued at $567,643.00 and spanning September 2024 through May 2029, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports research at Duke University focused on understanding the communication between alpha and beta cells, and its role in insulin secretion and glucose homeostasis, particularly in the context of...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $410,000.00 to The University of Texas Southwestern Medical Center to study the effects of glucagon-like peptide 1 (GLP-1) receptor agonists and brain-derived GLP-1 on the activity of neuropeptide Y/agouti-related peptide (NPY/AGRP) neurons and their impact on metabolism. The research aims to define the...
This $1,331,148 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports research to investigate the mechanisms by which pancreatic alpha cells can compensate for deficiencies in beta cell mass in type 2 diabetes. The key objectives are to: 1) Determine the signaling mechanisms underlying beta cell compensation in a mouse model of beta cell...
This $205,280 Project Grant award, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports a research project investigating the mechanisms driving the kinetics of incretin-mediated beta cell responses. The project aims to quantify the trafficking of incretin receptors and their influence on cAMP responses, as well as examine the interplay between cAMP and...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) provides $2,155,558.00 in funding to the Joslin Diabetes Center, Inc. to study the mechanisms underlying glucose toxicity and its impact on insulin biosynthesis and secretion in beta cells. The goal is to identify novel therapeutic targets to prevent progressive beta-cell failure in diabetes...